SW
REGN icon

SteelPeak Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

SteelPeak Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$144K – 446
2022
Q4 		– Hold
0
– – – 384

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

SteelPeak Wealth's REGN Position: Q2 2026 in Review

SteelPeak Wealth opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 21,939 shares worth $13.7M. The stake represents 0.35% of the portfolio and ranks #61 among its holdings. This is a return to the name: SteelPeak Wealth previously reported a position in REGN as recently as Q1 2025.

SteelPeak Wealth first reported a position in REGN in Q2 2021 and has held it in 10 quarters since. 582 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • SteelPeak Wealth held 21,939 shares of Regeneron Pharmaceuticals worth $13.7M as of Q2 2026.
  • Regeneron Pharmaceuticals was a new SteelPeak Wealth position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.35% of SteelPeak Wealth's portfolio in Q2 2026, its #61 holding.
  • SteelPeak Wealth first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 10 quarters since.
  • 582 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.